Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 28.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,699 shares of the company’s stock after acquiring an additional 825 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Nu Skin Enterprises were worth $305,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Aperio Group LLC lifted its position in Nu Skin Enterprises by 11.6% in the second quarter. Aperio Group LLC now owns 66,845 shares of the company’s stock valued at $5,227,000 after acquiring an additional 6,964 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its position in Nu Skin Enterprises by 396.1% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 83,865 shares of the company’s stock valued at $6,557,000 after acquiring an additional 66,960 shares during the last quarter. Comerica Bank lifted its position in Nu Skin Enterprises by 8.3% in the second quarter. Comerica Bank now owns 42,549 shares of the company’s stock valued at $3,241,000 after acquiring an additional 3,249 shares during the last quarter. New York State Teachers Retirement System lifted its position in Nu Skin Enterprises by 4.2% in the second quarter. New York State Teachers Retirement System now owns 20,000 shares of the company’s stock valued at $1,564,000 after acquiring an additional 800 shares during the last quarter. Finally, First Trust Advisors LP lifted its position in Nu Skin Enterprises by 110.3% in the second quarter. First Trust Advisors LP now owns 239,477 shares of the company’s stock valued at $18,725,000 after acquiring an additional 125,580 shares during the last quarter. 74.66% of the stock is currently owned by institutional investors.
In other news, General Counsel D Matthew Dorny sold 2,500 shares of the company’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $82.18, for a total value of $205,450.00. Following the completion of the sale, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders sold 7,500 shares of company stock valued at $537,625 over the last ninety days. Corporate insiders own 5.20% of the company’s stock.
Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 27.50%. The business had revenue of $675.31 million during the quarter, compared to analysts’ expectations of $664.99 million. During the same period in the previous year, the company posted $0.76 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 19.8% on a year-over-year basis. As a group, sell-side analysts predict that Nu Skin Enterprises, Inc. will post 3.51 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be issued a $0.365 dividend. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.29%. Nu Skin Enterprises’s payout ratio is 45.20%.
A number of equities research analysts recently weighed in on NUS shares. Tigress Financial reissued a “buy” rating on shares of Nu Skin Enterprises in a research report on Wednesday, November 21st. Citigroup set a $88.00 price target on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research report on Thursday, November 8th. Jefferies Financial Group reissued a “buy” rating and issued a $92.00 price target on shares of Nu Skin Enterprises in a research report on Thursday, November 8th. DA Davidson started coverage on shares of Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 price target for the company. Finally, Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research report on Monday, October 15th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $83.63.
TRADEMARK VIOLATION NOTICE: “Nu Skin Enterprises, Inc. (NUS) Position Boosted by Zurcher Kantonalbank Zurich Cantonalbank” was originally reported by BBNS and is owned by of BBNS. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://baseballnewssource.com/2018/12/08/nu-skin-enterprises-inc-nus-position-boosted-by-zurcher-kantonalbank-zurich-cantonalbank/3064720.html.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Article: What is the Dow Jones Industrial Average (DJIA)?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.